Herbal supplement recalled for unapproved drug claims and missing labeling
A New Life Herbs recalls Anti-virus Herbal Supplement due to unapproved antiviral claims and missing Supplement Facts label. 116 bottles were distributed across 12 states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall based on regulatory non-compliance: unapproved drug claims and missing required Supplement Facts label. No illnesses, injuries, or hospitalizations have been reported.
Plain-English summary
A New Life Herbs, LLC is recalling its Anti-virus Herbal Supplement, a 1:5 alcohol tincture containing Forsethia blossoms, Sumac berries, and Pine needles in 2 oz. glass dropper bottles. The product makes unapproved drug claims, stating it 'helps to stop viral replication' and has 'expectorant properties,' which are not permitted for dietary supplements without FDA approval.
The recalled product also lacks the required Supplement Facts label, a mandatory disclosure element for all dietary supplements sold in the United States.
The product was distributed in Alabama, Arizona, California, Georgia, Illinois, Indiana, Minnesota, Missouri, Mississippi, North Carolina, New York, and Tennessee. Affected lot codes are T801AV (EXP 9/30), T686AV (EXP 12/29), T636AV (EXP 9/29), and T564AV (EXP 9/28). A total of 116 bottles were affected.
Consumers who have purchased this product should stop using it. Those with questions may contact the manufacturer or their healthcare provider.
The recalled product
- Product
- Anti-virus Herbal Supplement, 1:5 Alcohol Tincture, Helps to stop viral replication, expectorant properties, Contains: Forsethia blossoms, Sumac berries, Pine needles; packaged in a 2 oz. glass dropper bottle, UPC 283162814429
- Manufacturer
- A New Life Herbs, LLC
- Category
- Drug — Herbal Supplement
- Hazard
- unapproved-drug-claims
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- T801AV EXP 9/30 T686AV EXP 12/29 T636AV EXP 9/29 T564AV EXP 9/28
Distribution
Distributed in 12 states:
- AL
- AZ
- CA
- GA
- IL
- IN
- MN
- MO
- MS
- NC
- NY
- TN
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27